A CLINICAL AND PHARMACOKINETIC (PK) PHASE-I STUDY OF RPR109881A, A NEW TAXOID ADMINISTERED AS A 3 HOUR INTRAVENOUS-INFUSION TO PATIENTS (PTS) WITH ADVANCED SOLID TUMORS
S. Caldiera et al., A CLINICAL AND PHARMACOKINETIC (PK) PHASE-I STUDY OF RPR109881A, A NEW TAXOID ADMINISTERED AS A 3 HOUR INTRAVENOUS-INFUSION TO PATIENTS (PTS) WITH ADVANCED SOLID TUMORS, Annals of oncology, 9, 1998, pp. 359-359